Notably, LIMA1 HKO exhibited systematic amelioration of MASLD‐related phenotypes, as indicated by the changes in hepatic steatosis, inflammatory cell infiltration, and hepatic fibrosis in HFD‐fed and CDAHFD‐fed mice. Here, LIMA1 is linked to Hepatic steatosis.